Peter Island Continous sunscreen

Product NDC
10056-711
11-digit product format
100560711
Labeler code
10056
Product ID
10056-711_54a41877-7106-4442-a228-1afd818ca525
Type
HUMAN OTC DRUG
Nonproprietary name
OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE
Dosage form
LOTION
Route
TOPICAL
Labeler
Access Business Group LLC
Application
part352
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2013-07-09
Marketing end
0000-00-00
Substance
OCTOCRYLENE; AVOBENZONE; OCTISALATE; HOMOSALATE
Active strength
10 g/100g; g/100g; g/100g; 1/100g
NDC exclude flag
E
Listing certified through
2018-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct10056-711IInactivated by FDA2026-08-11
excluded packagepackage10056-71110056-711-16IInactivated by FDA2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductIInactivated by FDAd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage10056-711-16IInactivated by FDAd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductIInactivated by FDAf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage10056-711-16IInactivated by FDAf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproductIInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage10056-711-16IInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproductIInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage10056-711-16IInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductIInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage10056-711-16IInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductIInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage10056-711-16IInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproductIInactivated by FDA302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage10056-711-16IInactivated by FDA302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproductIInactivated by FDAed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage10056-711-16IInactivated by FDAed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproductIInactivated by FDA0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage10056-711-16IInactivated by FDA0efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductIInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage10056-711-16IInactivated by FDAad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproductIInactivated by FDA367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage10056-711-16IInactivated by FDA367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproductIInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage10056-711-16IInactivated by FDA557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-28excluded productproductIInactivated by FDA8af77b9d5b6f…d9bbb34c5368…
2024-05-28 21:12 UTC · source 2024-05-28excluded packagepackage10056-711-16IInactivated by FDA8af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14excluded productproductIInactivated by FDA834df4deac94…adcc014656a3…
2024-05-15 03:39 UTC · source 2024-05-14excluded packagepackage10056-711-16IInactivated by FDA834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-08excluded productproductIInactivated by FDA1332a3947898…d4bfe170f9cd…
2024-03-11 06:39 UTC · source 2024-03-08excluded packagepackage10056-711-16IInactivated by FDA1332a3947898…d4bfe170f9cd…
2022-08-30 03:57 UTC · source 2022-08-29excluded productproductIInactivated by FDAfb8cb913e6d1…eb8c232b6be0…
2022-08-30 03:57 UTC · source 2022-08-29excluded packagepackage10056-711-16IInactivated by FDAfb8cb913e6d1…eb8c232b6be0…
2022-04-09 23:13 UTC · source 2022-04-08excluded productproductIInactivated by FDA86f5da6cb304…a595104c45d7…
2022-04-09 23:13 UTC · source 2022-04-08excluded packagepackage10056-711-16IInactivated by FDA86f5da6cb304…a595104c45d7…
2022-04-04 05:40 UTC · source 2022-04-01excluded productproductIInactivated by FDAbd6a592717d7…303034d00443…
2022-04-04 05:40 UTC · source 2022-04-01excluded packagepackage10056-711-16IInactivated by FDAbd6a592717d7…303034d00443…
2021-12-27 23:28 UTC · source 2021-12-27excluded productproductIInactivated by FDA8dfbde2a14a4…c9ff85d89658…
2021-12-27 23:28 UTC · source 2021-12-27excluded packagepackage10056-711-16IInactivated by FDA8dfbde2a14a4…c9ff85d89658…
2020-12-18 03:04 UTC · source 2020-12-17excluded productproductIInactivated by FDAe2bbac7714bc…27bdfed8d636…
2020-12-18 03:04 UTC · source 2020-12-17excluded packagepackage10056-711-16IInactivated by FDAe2bbac7714bc…27bdfed8d636…
2020-06-10 20:45 UTC · source 2020-06-10excluded productproductIInactivated by FDA9bebd1f3094a…5416666fcb17…
2020-06-10 20:45 UTC · source 2020-06-10excluded packagepackage10056-711-16IInactivated by FDA9bebd1f3094a…5416666fcb17…
2019-12-08 06:16 UTC · source 2019-12-05excluded productproductEExcluded after deficient or non-compliant submission was not corrected110d247fa046…a55b01930146…
2019-12-08 06:16 UTC · source 2019-12-05excluded packagepackage10056-711-16EExcluded after deficient or non-compliant submission was not corrected110d247fa046…a55b01930146…

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
10056-711-162020-01-31C16284748780-19d75b9cf-e6c3-f424-e053-dadaa90a57ceDrug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
10056-711-16Peter Island Continous sunscreenSPF 30226 g in 1 BOTTLE, PLASTICLOTION2261

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
AVOBENZONEACTIVE INGREDIENTG63QQF2NOXPETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
HOMOSALATEACTIVE INGREDIENTV06SV4M95SPETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
OCTISALATEACTIVE INGREDIENT4X49Y0596WPETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
OCTOCRYLENEACTIVE INGREDIENT5A68WGF6WMPETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
AVOBENZONEACTIVE MOIETYG63QQF2NOXPETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
HOMOSALATEACTIVE MOIETYV06SV4M95SPETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
OCTISALATEACTIVE MOIETY4X49Y0596WPETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
OCTOCRYLENEACTIVE MOIETY5A68WGF6WMPETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
ALOE VERA LEAFINACTIVE INGREDIENTZY81Z83H0XPETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
BENZYL ALCOHOLINACTIVE INGREDIENTLKG8494WBHPETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
CHLORPHENESININACTIVE INGREDIENTI670DAL4SZPETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
DIETHYLHEXYL SYRINGYLIDENEMALONATEINACTIVE INGREDIENT3V5U97P248PETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
EDETATE DISODIUMINACTIVE INGREDIENT7FLD91C86KPETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
ETHYLHEXYL PALMITATEINACTIVE INGREDIENT2865993309PETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
GLYCERYL MONOSTEARATEINACTIVE INGREDIENT230OU9XXE4PETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
OLETH-3INACTIVE INGREDIENTBQZ26235UCPETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
PEG-100 STEARATEINACTIVE INGREDIENTYD01N1999RPETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
SODIUM ASCORBYL PHOSPHATEINACTIVE INGREDIENT836SJG51DRPETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
SORBITOLINACTIVE INGREDIENT506T60A25RPETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
TOCOPHEROLINACTIVE INGREDIENTR0ZB2556P8PETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
TRICAPRININACTIVE INGREDIENTO1PB8EU98MPETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
TROLAMINEINACTIVE INGREDIENT9O3K93S3TKPETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1
WATERINACTIVE INGREDIENT059QF0KO0RPETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
10056-711PETER ISLAND CONTINOUS SUNSCREEN SPF 30 (OCTOCRYLENE AVOBENZONE OCTISALATE HOMOSALATE) LOTION [ACCESS BUSINESS GROUP LLC]1Legacy NDC, 1 package rows20130712_6fe0f50d-21b5-4d06-a119-ef80def51e20.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsStatus
10056-711-1610056071116226 g in 1 BOTTLE, PLASTIC226 gHistorical